Abstract
Purpose
Cancer-related fatigue (CRF) is an important symptom in clinical practice and research. The best way to measure it, however, remains unsettled. The SF-36 vitality scale, a general measure of energy/fatigue, is a frequently cited measure. With only four items, however, its ability to adequately represent multiple CRF facets has been questioned. The 13-item Fatigue Symptom Inventory (FSI) was developed to assess multidimensional aspects of CRF. Our objectives were to assess the convergent validity and to compare the sensitivity to change of the two scales.
Methods
We administered both scales at 1 month (n = 68) and 6 months (n = 96) to a subset of heterogeneous patients receiving treatment in 16 cancer centers who were enrolled in a clinical trial of pain and depression. Distributions of standardized response means (SRMs) were compared to assess sensitivity to change. Results of both scales were compared to scores on a single fatigue item from the Patient Health Questionnaire (PHQ).
Results
Mean scores for both the FSI and the vitality scale demonstrated clinically significant fatigue in the sample. The vitality scale was strongly correlated with all three FSI scales (r = −0.68 to −0.77). The vitality and FSI scales also correlated strongly with the PHQ fatigue item. Moreover, distributions of SRMs for both scales were approximately normal.
Conclusions
Both the FSI and the vitality scale are supported as valid measures of CRF. Both demonstrated sensitivity to change across a range of effect sizes. The vitality scale may be an excellent choice when brevity is paramount; the FSI may be more appropriate when tapping specific dimensions is warranted.
References
Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Supplement 1):4–10
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Cella D, Cimprich B, Cleeland CS, Eisenberger MA, Escalante CP, Hinds P, Jacobsen PB, Kaldor P, Ligibel JA, Loscalzo MJ, Murphy BA, O’Connor T, Pirl WF, Rodler E, Rugo HS, Wagner LI (2009) Nccn clinical practice guidelines in oncology: Cancer-related fatigue. National Comprehensive Cancer Network. 2009
Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Reid LD, Turrisi ATr, Unutzer J, Vernon SW (2002) Symptom management in cancer: pain, depression, and fatigue. NIH Consens Statements State Sci Statements 19(4):1–29
Brown LF, Kroenke K (2009) Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 50(5):440–447. doi:10.1176/appi.psy.50.5.440
Jacobsen PB (2004) Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:93–97
Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR (2007) Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12(Supplement 1):11–21
Cella D, Lai J-S, Stone A (2010) Self-reported fatigue: One dimension or more? Lessons from the functional assessmet of chronic illness therapy–fatigue (facit-f) questionnaire. Support Care Cancer Published online August 13:2010
Ware JE, Kosinski M, Keller SD (1994) Sf-36 physical and mental health summary scales: a user’s manual. The Health Institute, New England Medical Center, Boston
O’Connor PJ (2004) Evaluation of four highly cited energy and fatigue mood measures. J Psychosom Res 57:435–441
Kroenke K, Theobald D, Norton K, Sanders R, Schlundt S, McCalley S, Harvey P, Iseminger K, Morrison G, Carpenter JS, Stubbs D, Jacks R, Carney-Doebbeling C, Wu J, Tu W (2009) The indiana cancer pain and depression (incpad) trial: design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. Gen Hosp Psychiatry 31:240–253
Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter JS, Tu W (2010) Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA 304(2):163–171
Ware JE, Snow KK, Kosinski M, Gandek B (1993) Sf-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Center, Boston
Wu H-S, McSweeney M (2004) The assessment and measurement of fatigue in people with cancer. In: Armes J, Krishnasamy M, Higgenson I (eds) Fatigue in cancer. Oxford University Press, Oxford, pp 193–221
Donovan KA, Jacobsen PB, Small BJ, Munster PN, Andrykowski MA (2008) Identifying clinically meaningful fatigue with the fatigue symptom inventory. J Pain Symptom Manage 36(5):480–487
Shun S-C, Beck SL, Pett MA, Richardson SJ (2007) Assessing responsiveness of cancer-related fatigue instruments: distribution-based and individual-based anchors. Oncologist 12:495–504
Kroenke K, Spitzer RL, Williams JBW (2001) The phq-15: validity of a new measure for evaluating somatic symptom severity. Psychosomatic Medicine 64
Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R et al (2001) Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 286:2947–2955
Unutzer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler EM, Harpole L, Hoffing M, Della Penna RD, Noel PH, Lin EHB, Arean PA, Hegel MT, Tang L, Belin TR, Oishi S, Langston C (2002) Collaborative care management of late-life depression in the primary care setting. JAMA 288(22):2836–2845
Devo RA, Diehr P, Patrick DL (1991) Reproducibility and responsiveness of health status measures; statistics and strategies for evaluation. Control Clin Trials 12:142S–158S
Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH (1992) Comparative measurement sensitivity of short and longer health status instruments. Med Care 30(10):917–925
Wright JG, Young NL (1997) A comparison of different indices of responsiveness. J Clin Epidemiol 50(3):239–246
Jacobsen PB, Donovan KA, Weitzner M (2003) Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 8(4):229–240
Acknowledgments
This manuscript was supported by a grant from the National Cancer Institute to Dr. Kroenke (R01 CA-115369) and a grant from the National Cancer Institute (R25 CA-117865-01A11).
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brown, L.F., Kroenke, K., Theobald, D.E. et al. Comparison of SF-36 vitality scale and Fatigue Symptom Inventory in assessing cancer-related fatigue. Support Care Cancer 19, 1255–1259 (2011). https://doi.org/10.1007/s00520-011-1148-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1148-2